Your browser doesn't support javascript.
loading
Pharmacometric Analyses to Support Early Development Decisions for LY2878735: A Novel Serotonin Norepinephrine Reuptake Inhibitor.
Raddad, E; Melhem, M R; Sloan-Lancaster, J S; Miller, J W; Van Wart, S A; Rubino, C M.
Affiliation
  • Raddad E; Chorus, Lilly Research Laboratories, Eli Lilly & Company, Indianapolis, Indiana, USA.
CPT Pharmacometrics Syst Pharmacol ; 2: e66, 2013 Aug 21.
Article in En | MEDLINE | ID: mdl-23965782
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: CPT Pharmacometrics Syst Pharmacol Year: 2013 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: CPT Pharmacometrics Syst Pharmacol Year: 2013 Document type: Article Affiliation country: United States Country of publication: United States